Hemogenyx Pharmaceuticals Overview 2023
Videos & Presentations
Proactive Investors Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
Proactive Investors Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform
Investor Webinar 6 July 2022
ASH 2020 Presentation – CDX Antibody
Financing Facility & Trading Update
Development Agreement for Autoimmune Diseases
Fundraise Announcement 12 May 2020
Explainer Series #1: Hemogenyx Pharmaceuticals Introduction 1
Explainer Series #2: Hemogenyx Pharmaceuticals Introduction 2